Real-world heart procedure blood thinner patterns under the microscope

NCT ID NCT05193019

Ongoing Knowledge-focused Sponsor: Fundación EPIC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks how doctors in Spain use injectable blood thinners (cangrelor or GPIs) during heart procedures like stent placement. It includes 717 patients and will look at short-term outcomes like death, heart attack, stroke, and bleeding within 48 hours. The goal is to understand current practice and safety in real-world settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Parenteral antiplatelet agents (cangrelor or glycoprotein IIb/IIIa inhibitors)
What this could lead to: If successful, this could help doctors choose the best blood thinner for heart procedures, potentially reducing complications.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to other countries or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROME ISCHEMIC HEART DISEASE

Contacts and locations

Locations

H.de Leon

León, 24080, Spain
Hospital Central de La Defensa Gómez Ulla

Madrid, 28047, Spain
Hospital Clinico Universitario Santiago de Compostela

Santiago de Compostela, 15706, Spain
Hospital Clinico Universitario de Salamanca

Salamanca, 37007, Spain
Hospital Universitari Joan Xxiii

Tarragona, 43005, Spain
Hospital Universitari de Bellvitge

L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Hospital Universitario Lozano Blesa

Zaragoza, 50009, Spain
Hospital Universitario Marques de Valdecilla

Santander, 39008, Spain
Hospital Universitario de Cabueñes

Gijón, 33394, Spain
Hospital Universitario de Cruces

Barakaldo, 48903, Spain
Hospital Universitario de Navarra

Pamplona, 31008, Spain
Hospital de Galdakao

Galdakao, 48960, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.